Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
- 19 April 2012
- journal article
- research article
- Published by Elsevier BV in Cell Metabolism
- Vol. 15 (5), 725-738
- https://doi.org/10.1016/j.cmet.2012.03.015
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- Postprandial Hepatic Lipid Metabolism Requires Signaling through Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1cCell Metabolism, 2011
- mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP PathwayCell, 2011
- Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent PathwaysCell Metabolism, 2011
- Targeting the mTOR kinase domain: the second generation of mTOR inhibitorsDrug Discovery Today, 2011
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1Molecular Cell, 2010
- Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin ResistanceCell Metabolism, 2009
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell GrowthCell Metabolism, 2008
- The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase CThe EMBO Journal, 2008
- Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signallingThe EMBO Journal, 2008
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001